Anidulafungin Susceptibility Testing of Candida glabrata Isolates from Blood Cultures by the MALDI Biotyper Antibiotic (Antifungal) Susceptibility Test Rapid Assay

被引:16
|
作者
Vatanshenassan, Mansoureh [1 ,2 ]
Arastehfar, Amir [2 ,3 ]
Boekhout, Teun [2 ,3 ]
Berman, Judith [4 ]
Lass-Floerl, Cornelia [5 ]
Sparbier, Katrin [1 ]
Kostrzewa, Markus [1 ]
机构
[1] Bruker Daltonik GmbH, Bremen, Germany
[2] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands
[3] Westerdijk Fungal Biodivers Inst, Utrecht, Netherlands
[4] Tel Aviv Sourasky Med Ctr, Infect Dis Unit, Tel Aviv, Israel
[5] Med Univ, Div Hyg & Microbiol, Innsbruck, Austria
基金
欧盟地平线“2020”;
关键词
C; glabrata; MBT ASTRA; anidulafungin; positive blood samples; rapid antifungal susceptibility testing; DESORPTION IONIZATION-TIME; FLIGHT MASS-SPECTROMETRY; ECHINOCANDIN RESISTANCE; FKS MUTATIONS; EPIDEMIOLOGY; IDENTIFICATION; OUTCOMES; VALUES; DNA;
D O I
10.1128/AAC.00554-19
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Echinocandins are the recommended first-line antifungals for treatment of invasive candidiasis. The increasing number of Candida glabrata strains resistant against echinocandins is an emerging health care concern. The rapid detection of resistant C. glabrata isolates is an urgent requirement for clinical laboratories. In this study, we developed the MALDI Biotyper antibiotic (antifungal) susceptibility test rapid assay (MBT ASTRA) for the rapid detection of anidulafungin-resistant C. glabrata isolates directly from positive blood cultures. Of 100 C. glabrata strains, MBT ASTRA classified 69 as susceptible and 29 as resistant. Microdilution assays performed according to the Clinical and Laboratory Standards Institute (CLSI) guidelines, used as a standard reference, identified 65 susceptible, 9 intermediate, and 26 resistant isolates. Sequencing of hot spot 1 and hot spot 2 regions of the FKS1 and FKS2 genes classified 86 susceptible and 14 resistant isolates. The MBT ASTRA had sensitivity and specificity of 80% and 95%, respectively, compared to the microdilution method. Positive and negative agreement of MBT ASTRA was calculated at 100% and 80%, respectively, compared with the molecular sequencing approach. Together, these results revealed a high accuracy of MBT ASTRA compared to microdilution according to the CLSI and PCR analysis, resulting in a categorical agreement of 90% and 83%, respectively. The validity of MBT ASTRA was 98%. Importantly, MBT ASTRA provided antifungal susceptibility testing (AFST) within 6 h that was both accurate and reliable compared to the other two approaches, which require at least 24 h or are costly. Therefore, this method has the potential to facilitate clinical AFST rapidly at low sample costs for clinical labs already equipped with matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS).
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Antimicrobial susceptibility testing of Bacteroides fragilis using the MALDI Biotyper antibiotic susceptibility test rapid assay (MBT-ASTRA)
    Justesen, Ulrik Stenz
    Acar, Ziyap
    Sydenham, Thomas Vognbjerg
    Johansson, Asa
    ANAEROBE, 2018, 54 : 236 - 239
  • [2] A Rapid and Easy Method of MALDI Biotyper Antibiotic Susceptibility Test Rapid Assay To Provide Early Meropenem Susceptibility Profile in Enterobacterales
    Wilhelm, Camila Morschbacher
    Carneiro, Maiara dos Santos
    Inamine, Everton
    Barth, Afonso Luis
    MICROBIOLOGY SPECTRUM, 2023, 11 (01):
  • [3] Rapid detection of tetracycline resistance in bovine Pasteurella multocida isolates by MALDI Biotyper antibiotic susceptibility test rapid assay (MBT-ASTRA)
    Van Driessche, Laura
    Bokma, Jade
    Gille, Linde
    Ceyssens, Pieter-Jan
    Sparbier, Katrin
    Haesebrouck, Freddy
    Deprez, Piet
    Boyen, Filip
    Pardon, Bart
    SCIENTIFIC REPORTS, 2018, 8
  • [4] Rapid antibiotic susceptibility testing on blood cultures using MALDI-TOF MS
    Sauget, Marlene
    Bertrand, Xavier
    Hocquet, Didier
    PLOS ONE, 2018, 13 (10):
  • [5] Diversity and antifungal susceptibility of Norwegian Candida glabrata clinical isolates
    Andersen, Kari-Mette
    Kristoffersen, Anne Karin
    Ingebretsen, Andre
    Vikholt, Katharina Johnsen
    Ortengren, Ulf Thore
    Olsen, Ingar
    Enersen, Morten
    Gaustad, Peter
    JOURNAL OF ORAL MICROBIOLOGY, 2016, 8
  • [6] Candida auris Identification and Rapid Antifungal Susceptibility Testing Against Echinocandins by MALDI-TOF MS
    Vatanshenassan, Mansoureh
    Boekhout, Teun
    Meis, Jacques F.
    Berman, Judith
    Chowdhary, Anuradha
    Ben-Ami, Ronen
    Sparbier, Katrin
    Kostrzewa, Markus
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2019, 9
  • [7] Antifungal Susceptibility Testing of Candida Isolates from the Candida Surveillance Study
    Lyon, G. Marshall
    Karatela, Sulaiman
    Sunay, Susan
    Adiri, Yaffa
    JOURNAL OF CLINICAL MICROBIOLOGY, 2010, 48 (04) : 1270 - 1275
  • [8] Strategy for Rapid Identification and Antibiotic Susceptibility Testing of Gram-Negative Bacteria Directly Recovered from Positive Blood Cultures Using the Bruker MALDI Biotyper and the BD Phoenix System
    Wimmer, Jana L.
    Long, S. Wesley
    Cernoch, Patricia
    Land, Geoffrey A.
    Davis, James R.
    Musser, James M.
    Olsen, Randall J.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2012, 50 (07) : 2452 - 2454
  • [9] Direct antifungal susceptibility testing of positive Candida blood cultures by Sensititre YeastOne
    Avolio, Manuela
    Grosso, Shamanta
    Bruschetta, Graziano
    De Rosa, Rita
    Camporese, Alessandro
    NEW MICROBIOLOGICA, 2009, 32 (02): : 179 - 184
  • [10] Prevalence and antifungal susceptibility patterns of new cryptic species inside the species complexes Candida parapsilosis and Candida glabrata among blood isolates from a Spanish tertiary hospital
    Miranda-Zapico, Ilargi
    Eraso, Elena
    Luis Hernandez-Almaraz, Jose
    Monica Lopez-Soria, Leyre
    Javier Carrillo-Munoz, Alfonso
    Manuel Hernandez-Molina, Juan
    Quindos, Guillermo
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (10) : 2315 - 2322